NCT01111188 2019-06-27Trial of PD 0332991 Plus Bortezomib in Patients With Relapsed Mantle Cell LymphomaWeill Medical College of Cornell UniversityPhase 1 Terminated20 enrolled
NCT00420056 2015-10-28An Investigational Study Drug, Palbociclib (PD-0332991), Is Being Studied In Patients With Mantle Cell Lymphoma. Patients Must Have Received Prior Treatment(s) For Mantle Cell Lymphoma.PfizerPhase 1 Completed17 enrolled 22 charts